Empresaria Group plc provided earnings guidance for the year ended December 31, 2015. For the year, the company expects adjusted profit before tax growth of approximately 23% year on year, with net fee income approximately 10% ahead of the prior year. Total net debt is expected to reduce by 26% from £9.8 million in 2014 to £7.3 million in 2015, which includes the term loan, as announced in October 2015, to help fund the acquisition of Pharmaceutical Strategies in the USA.